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Abstract: 
 
In research focused on the discovery of new chemical diversity from freshwater fungi, a peak 
library was built and evaluated against a prostate cancer cell line, E006AA-hT, which was 
derived from an African American, as this population is disproportionately affected by prostate 
cancer. The chemical study of the bioactive sample accessioned as G858 (Delitschia sp.) led to 
the isolation of eight new α-pyrone derivatives (1 – 7, and 11), as well as the new 3S*,4S*-7-
ethyl-4,8-dihydroxy-3,6-dimethoxy-3,4-dihydronaphthalen-1(2H)-one (15). In addition, the 
known compounds 5-(3-S-hydroxybutyl)-4-methoxy-6-methyl-2H-pyran-2-one (8), 5-(3-
oxobutyl)-4-methoxy-6-methyl-2H-pyran-2-one (9), pyrenocine I (10), 5-butyl-6-
(hydroxymethyl)-4-methoxy-2H-pyran-2-one (12), sporidesmin A (13), 6-ethyl-2,7-
dimethoxyjuglone (14), artrichitin (16), and lipopeptide 15G256ε (17) were also obtained. The 
structures of the new compounds were elucidated using a set of spectroscopic (NMR) and 
spectrometric (HRMS) methods. The absolute configuration of the most abundant member of 
each subclass of compounds was assigned through a modified Mosherʼs ester method. For 15, 
the relative configuration was assigned based on analysis of 3 J values. Compounds 1, 2, 5 – 14, 
16, and 17 were evaluated against the cancer cell line E006AA-hT under hypoxic conditions, 
where compound 13 inhibited cell proliferation at a concentration of 2.5 µM. 
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Article: 
 
Introduction 
 
The fungal kingdom, estimated at 2.2 – 3.8 million species, with just 3 to 8% identified (120 000) 
[1], is the second most diverse on the planet [2]. Among those, the freshwater ascomycetes are 
underinvestigated, with only about 675 species described [3]. This diverse ecological group 
relies upon freshwater for the whole or part of their life cycle [3], [4] and includes any species 
growing on substrates that are aquatic or semiaquatic [4]. Freshwater fungi play an important 
role in the degradation of organic materials [5]. Chemically, the ability of freshwater 
ascomycetes to produce bioactive metabolites merits investigation, as less than 250 metabolites 
have been described [6]. Thus, to contribute to the expansion of the chemical space of secondary 
metabolites from this ecological niche, our team has started a systematic study of bioactive 
compounds from freshwater ascomycetes [7]. Recent examples include five acetophenone 
derivatives [8] and 14 resorcylic acid lactones with cytotoxic activity [9], as well as 
isochromenones, isobenzofuranones, and tetrahydronaphthalenes [10]. 
 
According to Index Fungorum (http://www.indexfungorum.org/names/names.asp) and the 
Dictionary of Fungi [11], the genus Delitschia Auersw. (Delitschiaceae) comprises coprophilous 
and saprobic taxa with around 83 species; another resource (Genera of Ascomycota) lists a more 
conservative 52 species. Despite the diversity in this genus, only a handful have been 
investigated for bioactive secondary metabolites. Interestingly, the few chemical studies 
conducted of this genus have led to the isolation of compounds with new scaffolds, such as 
delitschiapyrone A [12], an α-pyrone-naphthalenone adduct, and a fimetarone derivative [13]. 
 
In the USA, African American men have the highest risk of both developing and dying of 
prostate cancer, relative to Caucasians [14], [15], and there are many social, economic, and 
biological factors that contribute to this health disparity [15]. Hence, with the goals of 
understanding the biology and ameliorating this disease, we have initiated a project focused on 
the discovery of research tools and drug leads for the treatment of prostate cancer in African 
Americans. Hypoxia (low oxygen conditions) in prostate tumors is an early event associated with 
an aggressive phenotype. Hypoxic conditions in the tumor microenvironment promote genetic, 
metabolic, and proteomic changes, which lead to increased glycolysis, angiogenesis, survival, 
stemness, invasiveness, and selection of resistant clones [16]. Levels of hypoxia in prostate 
tumors, and expression of hypoxia-related biomarkers (e.g., hypoxia-inducible factor HIF1α and 
HIF2α), are associated with poor prognosis and are the major reasons for treatment failure and 
disease relapse [16]. Therefore, we assessed the effect of potential drugs against African 
American prostate cancer cells under hypoxic conditions. 
 
In this context, a study of the aquatic fungus Delitschia sp. (strain G858) led to the isolation and 
characterization of eight new structurally related α-pyrone derivatives (1 – 7, and 11), as well as 
one new dihydronaphthalenone (15), along with eight known fungal metabolites (8 – 10, 12 – 14, 
16, and 17). The cytotoxic activities of compounds 1, 2, 5 – 14, 16, and 17 were evaluated against 
the E006AA-hT cell line, where compound 13 showed promising bioactivity. 
 
Results and Discussion 
 
A library of 64 freshwater fungal isolates from diverse habitats (Fig. 58S, Supporting 
Information), arrayed across 320 peaks, was assembled using an 8-step procedure. Starting with 
a mature fungal culture, the sample was first extracted and then fractionated into four peaks. 
These samples were used to generate mother plates (10 mg/mL), daughter plates (5 mg/mL), and 
granddaughter plates (5 µg/well); each plate represented 16 fungi over 80 wells (16 extracts plus 
4 fractions from each). The plates were evaluated in a panel of bioassays, and hits were 
prioritized and dereplicated [17], [18]. The parent samples of active fractions were then used for 
isolation and elucidation of the hits, and this included fungal culture scale-up, when needed. 
Finally, pure compounds were evaluated for biological activities ([Fig. 1]). 
 
 
Figure 1. Strategy for uncovering new natural products from fungal peak libraries. The procedure starts with the 
sampling and isolation of axenic fungal strains, followed by fermentation, extraction, and fractionation into peaks. 
The peaks are used to generate mother plates, daughter plates, and granddaughter plates; each plate represents 16 
fungal isolates over 80 wells (16 extracts plus 4 fractions from each). The plates are then evaluated in a panel of 
bioassays, and hits are prioritized and dereplicated. The parent samples of active fractions are used for isolation and 
elucidation of hits. Finally, pure compounds are evaluated for biological activities. 
 
The library was tested against an African American prostate cancer cell line (E006AA-hT) under 
hypoxic conditions (1% O2), where cancer cells are more drug resistant [19], [20]. Promising 
bioactivity was observed with peaks derived from strain G858 (20% viability when tested at a 
concentration of 2 µg/mL) (Fig. 1S, columns 1 and 3, Supporting Information). These samples 
displayed an HPLC-UV profile that indicated a series of related analogues (Supporting 
Information), which could not be identified using the dereplication protocols [17], [18]. 
 
A large-scale culture of G858 (Delitschia sp.) was grown on rice and extracted using protocols 
described previously [21]. The resultant extract was partitioned using organic solvents and 
fractionated using flash chromatography, yielding nine fractions. These were purified further 
using preparative and semipreparative HPLC to yield nine new natural products (1 – 7, 11, 
and 15), along with the known compounds 5-(3-S-hydroxybutyl)-4-methoxy-6-methyl-2H-
pyran-2-one (8) [22], 5-(3-oxobutyl)-4-methoxy-6-methyl-2H-pyran-2-one (9) [23], pyrenocine I 
(10) [24], 5-butyl-6-(hydroxymethyl)-4-methoxy-2H-pyran-2-one (12) [23], sporidesmin A (13) 
[25], 6-ethyl-2,7-dimethoxyjuglone (14) [12], [26], artrichitin (16) [27], and lipopeptide 
15G256ε (17) [28] ([Fig. 2]). The structures of the isolates were established using spectroscopic 
and spectrometric data, which for all known compounds compared favorably to the literature. 
The absolute configuration of an illustrative member of each subclass was assigned through a 
modified Mosherʼs ester method [29]. 
 
 
Figure 2. Structures of compounds 1 – 17. 
 
Compound 1 was isolated as a colorless solid, and its molecular formula was C11H16O4 on the 
basis of the HRESIMS data (m/z 213.1125), indicating an index of hydrogen deficiency of four. 
The 1H- and 13C-NMR spectra ([Tables 1] and [2], Figs. 5S and 6S, Supporting Information) in 
combination with HSQC data showed signals attributed to one olefinic proton (δ H/δ C 5.49/89.1), 
one methoxy group (δ H/δ C 3.86/56.3), one –OH (δ H 2.44), two 
CH2 (δ H/δ C 1.64/1.86/39.4; δ H/δ C 1.28/1.42/19.5), and two CH3 groups 
(δ H/δ C 0.93/14.0; δ H/δ C 2.29/17.9), as well as four quaternary carbons, including three olefinic 
(δ C 170.6, 113.2, and 159.1) and one carbonyl (δ C 164.0), attributed to an α,β unsaturated 
lactone. In general, these data showed notable similarity to that of (R)-5-(1-hydroxybutyl)-4-
methoxy-6-methyl-2H-pyran-2-one, an α-pyrone derivative isolated from Alternaria 
phragmospora [23]. In our study, the absolute configuration at C-1′ in 1 was established as S by 
comparison of its specific rotation ([α]D 27 = − 15) with that reported for its enantiomer (1′R)-
2′,3′-dihydropyrenocine C ([α]D 27 = + 15.7) [12], and based on the outcomes obtained after 
applying a modified Mosherʼs method ([Fig. 3]) [29]. Thus, compound 1 was identified as (1′S)-
2′,3′-dihydropyrenocine C, and assigned the trivial name delitpyrone A (1). 
 
Table 1. 1H-NMR data for compounds 1 – 3, 5 – 7, and 11. 
Position δ H, multiplicity (J = Hz) 
1 2 3 5 6 7 11 
3 5.49, s 5.45, s 5.54, s 5.48, s 5.46, s 5.58, s 5.47, s 
1′ 4.63, q (6.5) 3.71, d (4.0) 5.15, d (6.2) 4.98, d (3.5) 3.42, s 2.41, dd (14.1, 
8.6) 
2.58, dd (14.1, 
4.2) 
3.48, d (17.9); 
3.55, d (17.9) 
2′ 1.64, ddt (13.5, 
10.2, 6.1) 
1.86, dddd (13.4, 
10.1, 8.0, 5.3) 
3.10, ddd (6.9, 
5.2, 4.1) 
4.52, q (6.2) 
  
3.55, tt (8.5, 
4.4) 
 
3′ 1.28, m; 1.42, m 1.25, dp (14.4, 
7.3) 
1.35, m 
1.77, m 
1.86, dp (14.7, 
7.4) 
2.35, q (7.5); 
2.35, qd (7.5, 
0.5) 
2.50, q (7.3) 1.46, m; 1.53, m 4.38, dq (6.9, 
5.0) 
4′ 0.93, t (7.4) 0.99, t (7.5) 1.06, t (7.4) 1.11, t (7.3) 1.09, t (7.3) 0.98, t (7.4) 1.47, d (7.1) 
4-OCH3 3.86, s 3.82, s 3.89, s 3.78, s 3.78, s 3.88, s 3.77, s 
6-CH3 2.29, s 2.34, s 2.34, s 2.33, s 2.17, s 2.28, s 2.19, s 
1′-OH 2.44, d (7.7) 
  
4.02, d (3.7) 
   
3′-OH 
      
3.28, d (5.0) 
For solvents and magnetic field used for each compound, see the Materials and Methods section 
 
Table 2. 13C-NMR data for compounds 1 – 3, 5 – 7, and 11. 
Position δ C, type 
1 2 3 5 6 7 11 
2 164.0 C 164.3 C 162.5 C 163.3 C 164.3 C 167.4 C 169.5 C 
3 89.1 CH 87.6 CH 89.4 CH 88.6 CH 88.0 CH 88.3 CH 88.2 CH 
4 170.6 C 170.2 C 169.2 C 169.2 C 170.0 C 173.4 C 164.0 C 
5 113.2 C 106.8 C 107.1 C 109.6 C 105.8 C 110.9 C 104.8 C 
6 159.1 C 161.7 C 154.4 C 162.9 C 160.1 C 161.4 C 160.4 C 
1′ 68.7 CH 51.7 CH 76.7 CH 71.6 CH 37.8 CH2 33.1 CH2 33.6 CH2 
2′ 39.4 CH2 58.7 CH 81.7 CH 208.7 C 207.0 C 73.4 CH 208.5 C 
3′ 19.5 CH2 21.8 CH2 28.1 CH2 30.8 CH2 35.6 CH2 31.1 CH2 72.7 CH 
4′ 14.0 CH3 10.4 CH3 8.9 CH3 7.9 CH3 8.0 CH3 10.7 CH3 20.2 CH3 
4-OCH3 56.3 CH3 56.2 CH3 56.9 CH3 56.4 CH3 56.4 CH3 57.1 CH3 56.5 CH3 
6-CH3 17.9 CH3 18.2 CH3 17.8 CH3 17.7 CH3 17.6 CH3 17.9 CH3 17.7 CH3 
For solvents and magnetic field used for each compound, see the Materials and Methods section 
 
 
Figure 3. Δδ H values [Δδ (in ppm) = δS – δR] obtained for compounds 1, 7, and 8. 
 
Compound 2 was obtained as a colorless solid. The molecular formula was C11H14O4 based on 
the HRESIMS data (m/z 211.0955), indicating five degrees of unsaturation. The 1D-NMR 
spectra of 2 were similar to those of 1, except for the chemical shift of the proton and carbon 
signals attributed to the oxymethine at C-1′ in 1 (δ H/δ C 4.63/68.7), which were both relatively 
more shielded in 2 (δ H/δ C 3.71/51.7). Additionally, the replacement of a methylene group 
in 1 for an oxymethine group (δ H/δ C 3.10/58.7) in 2, as well as the increase in the unsaturation 
number, indicated 2 as 1′,2′-epoxi-delitpyrone A (2). Key HMBC correlations ([Fig. 4]) 
confirmed the structure of 2. The spatial orientation of the substituent at position 1′ was 
considered to be the same as in compound 1 based on the specific rotation ([α]D 27 = − 5) and 
biogenetic considerations. The coupling constant (J H-1′/H-2′ = 4.0 Hz) did not permit a clear 
consideration of the orientation across the epoxide [30]. However, the isolation from this strain 
of the E oriented putative biosynthetic precursor of 2 (data not shown), as well as other 
analogues, supported the trans disposition of the substituents in the oxirane. Thus, the absolute 
configuration of 2 was presumed to be 1′R,2′R. While the absolute configuration at C-1′ in 1 is Ş 
it became R in 2, based on the Cahn-Ingold-Prelog rules. 
 
 
Figure 4. Key HMBC correlations of compounds 1 – 3, 5 – 7, 11, and 15. 
 
Compound 3 (delitpyrone B) was isolated as a colorless solid, and its molecular formula was 
C11H16O5 based on the HRESIMS data (m/z 229.1068). The NMR data for 3 resembled those for 
1′,2′-epoxi-delitpyrone A (2). Key differences were the deshielding of the methine groups at C-1′ 
and C-2′ (δ H/δ C 5.15/76.7 and 4.52/81.7, respectively) ([Tables 1] and [2]), indicating the 
opening of the epoxide moiety by the nucleophilic substitution of water, yielding the diol 
congener of 2. HMBC correlations ([Fig. 4]) further confirmed the structure of 3. The absolute 
configuration of compound 3 was proposed as 1′R and 2′S based on biogenic considerations. 
 
Delitpyrone C (4) was isolated as a colorless solid, and its molecular formula was C11H14O4 
according to the HRESIMS data at m/z 211.0962, indicating five degrees of unsaturation. The 
1H-NMR for 4 was quite different than those recorded for 1 – 3; for example, the characteristic 
methyl signal at δ H ~ 2.3 ppm (6-CH3) was replaced by two vinylic protons at δ H 4.81 
(d, J = 1.9) and 5.07 (d, J = 1.9). Additionally, comparison of the 1H-NMR data of 4 with that 
of 3 indicated the replacement of the oxymethine group at C-1′ with a vinylic proton δ H 6.49 
(d, J = 9.3) ([Table 3]). Altogether, this information indicated 4 as the dehydration product of 3. 
Unfortunately, the 2D-NMR data for compound 4 were not collected due to the instability of the 
compound and the paucity of the sample. Interestingly, this compound was recently proposed as 
an intermediate in the biosynthesis of delitschiapyrone A, a pyrone-naphthalenone adduct 
isolated from the leaf-associated fungus Delitschia sp. FL1581 [12]. The isolation of 4 from a 
related species both supports the biosynthetic proposal [12] and suggests the conservation of 
biosynthetic machinery within this genus. 
 
Table 3. NMR spectroscopic data for compound 4 (500 and 125 MHz, 1H and 13C, respectively), 
recorded in acetone-d 6. 
Position δ C, type δ H, multiplicity (J = Hz) 
2 162.2 C 
 
3 78.7 CH 5.36, s 
4 167.0 C 
 
5 123.5 C 
 
6 150.2 C 
 
1′ 139.8 CH 6.49, d (9.3) 
2′ 69.3 CH 4.48, m 
3′ 31.2 CH2 1.60, m 
1.67, m 
4′ 10.0 CH3 0.99, t (7.4) 
4-OCH3 57.1 CH3 3.92, s 
6-CH2a 90.6 CH2 4.81, d (1.9) 
6-CH2b 
  
5.07, d (1.9) 
 
Compound 5 (2′-oxodelitpyrone A), the 2′-oxo analogue of delitpyrone A, was obtained as a 
colorless solid. The molecular formula was C11H14O5 according to the HRESIMS data 
(m/z 227.0916). Analysis of the 1H- and 13C-NMR data ([Tables 1] and [2]) indicated that 5 
shares the same core as 1, with slight modifications in the side chain. The main difference was 
the replacement of the methylene group at the C-2′ position in 1 by a carbonyl group (δ C 208.7) 
in 5. The structure of 5 was confirmed through the analysis of the HMBC spectrum ([Fig. 4]). 
The spatial orientation of the hydroxy group in 5 was presumed to be in a β orientation by 
comparison of its specific rotation ([α]D 27 = − 38) with that recorded for 1. However, the 
absolute configuration at C-1′ was assigned as R. 
 
Delitpyrone D (6) was isolated as a colorless solid, and its molecular formula was C11H14O4 
according to the HRESIMS data (m/z 211.0967). The 1H and 13C-NMR data ([Tables 1] and [2]) 
were found to be similar with those of 5, with a difference observed in the chemical shift 
attributed to C-1′. Briefly, the oxymethine group in 5 (δ H/δ C 4.98/71.6) was replaced by a 
methylene group in 6 (δ H/δ C 3.42/37.8). The splitting pattern of H3-4′ (t) and H2-3′ (q), as well 
as key HMBC correlations from H2-1′and H2-3′ to a ketone carbonyl group at C-2′ ([Fig. 4]), 
confirmed the structure of 6 as 1′-dehydroxy-2′-oxodelitpyrone A. 
 
Compounds 7 and 8 (a known compound) were isolated as structural isomers sharing the 
molecular formula C11H16O4, as determined by the HRESIMS data (m/z 213.1122 and 213.1121, 
respectively), with an index of hydrogen deficiency of four. The 1H- and 13C-NMR data for both 
compounds were similar to each other. In the case of 7, signals for two methine groups, one 
vinylic proton (δ H/δ C 5.58/88.3, s for H-3/C-3), one oxymethine (δ H/δ C 3.55/73.4, C-2′), two 
methylene [(δ H/δ C 2.41/2.58/33.1 for H-1′a/H-1′b/C-1′) and (δ H/δ C 1.46/1.53/31.1 for H-3′a/H-
3′b/C-3′)], and one methyl group (δ H/δ C 0.98/10.7, t, J = 7.4 Hz for H3-4′/C-4′) were observed. 
Inspection of the splitting patterns in the 1H-NMR spectra, together with HMBC correlations, 
established the structure of 7 as 5-(2-hydroxybutyl)-4-methoxy-6-methyl-2H-pyran-2-one, which 
was assigned the trivial name delitpyrone E. The absolute configurations at the chiral center 
in 7 (C-2′) was established as S via the modified Mosherʼs ester method ([Fig. 3]). 
 
Compound 11 was isolated as a colorless solid, and its molecular formula was C11H14O5 on the 
basis of the HRESIMS (m/z 227.0914), indicating five degrees of unsaturation. The 1D-NMR 
spectra were similar with those of 6, with the exception of the signals attributed to protons and 
carbons at positions 3′ and 4′. Thus, the triplet and quartet in 6 (δ H/δ C 2.50/35.6, q, J = 7.3 Hz 
for H-3′/C-3′; 1.09/8.0, t, J = 7.3 Hz for H3-4′/C-4′) were replaced by a doublet of quartets for an 
oxymethine and a methyl doublet in 11 (δ H/δ C 4.38/72.7, dq, J = 6.9, 5.0 Hz for H-3′/C-3′; 
1.47/20.2, d, J = 7.1 Hz for H3-4′/C-4′). Thus, 11 was determined to be 3′-hydroxydelitpyrone D, 
and its structure was confirmed by analysis of the HMBC spectrum ([Fig. 4]). The absolute 
configuration at C-3′ was presumed to be S based on biogenic considerations. The biosynthesis 
for compounds 1 – 11 is proposed (Fig. 56S, Supporting Information). 
 
Compound 15 was isolated as a yellow solid, and its molecular formula was determined as 
C14H18O5 by HRESIMS analysis (m/z 267.1224). The 1D- and 2D-NMR data for this compound 
suggested structural similarity with the known compound 6-ethyl-2,7-dimethoxyjuglone (14) 
[31], [32]. The key differences were the replacement of one sp 2 methine in 14 by a shielded 
methylene group at δ H/δ C (2.56; 3.15/40.9, dd, J = 16.8, 10.5 Hz; dd, J = 16.8, 4.4 Hz for H-
3a/H-3b/C-3) in 15, as well as the 13C signals at C-4 and C-1 that were shielded from δ C 179.8 to 
72.1, and deshielded from δ C 190.9 to 199.4, respectively, supporting the reduction of the p-
naphthoquinone in 14 to a dihydronaphthalen-1(2H)-one moiety in 15 ([Table 4]). Inspection of 
the splitting patterns of signals, together with HMBC correlations ([Fig. 4]), established the 
structure of 15 as 7-ethyl-4,8-dihydroxy-3,6-dimethoxy-3,4-dihydronaphthalen-1(2H)-one. The 
relative configurations at positions C-3 and C-4 were established based on the analysis of 
coupling constant values and by comparison of the 1H-NMR data collected for 15 with that 
reported for (3S,4S)-3,4,8-trihydroxy-3,4-dihydro-1(2H)-naphthalenone [33]. Briefly, a trans-
pseudoaxial orientation between H-3 and H-4 was evident by the coupling constant 3 JH-3-H-
4  = 8.7 Hz, placing the hydroxy and methoxy substituents in an anti-orientation. Therefore, 
compound 15 was characterized as 3S*,4S*-7-ethyl-4,8-dihydroxy-3,6-dimethoxy-3,4-
dihydronaphthalen-1(2H)-one. 
Table 4. NMR data for compound 15 (700 and 175 MHz, 1H and 13C, respectively), recorded in 
CDCl3. 
Position δ C type δ H, multiplicity (J = Hz) 
1 199.4 C 
 
2 40.9 CH2 2.56, dd (16.8, 10.5) 
3.15, dd (16.8, 4.4) 
3 80.4 CH 3.60, ddd (10.6, 8.7, 4.4) 
4 72.1 CH 4.71, dd (8.8, 2.1) 
4a 142.6* C 
 
5 100.3 CH 6.80, s 
6 164.3 C 
 
7 118.8 C 
 
8 161.8 C 
 
8a 110.1 C 
 
1′ 15.7 CH2 2.65, q (7.5) 
2′ 13.3 CH3 1.08, t (7.5) 
3-OCH3 57.2 CH3 3.49, s 
6-OCH3 56.0 CH3 3.94, s 
4-OH 
  
2.90, s 
8-OH 
  
12.62, s 
* Signal obtained from HMBC spectrum 
 
 
Figure 5. Cytotoxic activity of compounds 1, 2, 5 – 14, 16, and 17 against the African American prostate cancer cell 
line E006AA-hT. The percentage viability was calculated by comparing the absorbance of control and treated cells. 
Data represent the mean ± SE of five replicates; *p < 0.05, **p < 0.01, ****p < 0.0001, significant when compared 
to control. 
 
The antiproliferative activities of compounds 1, 2, 5 – 14, 16, and 17 were evaluated against the 
African American prostate cancer cell line (E006AA-hT) under hypoxic conditions ([Fig. 5]). Of 
these, sporidesmin A (13) strongly inhibited the viability of the E006AA-hT cells in a 
concentration-dependent manner and was effective even at the lowest concentration tested, i.e., 
2.5 µM (Fig. 2S, Supporting Information). Compounds 2 and 6-ethyl-2,7-dimethoxyjuglone (14) 
also showed moderate growth inhibitory activity, especially at the highest concentration of 
40 µM ([Fig. 5]). 
 
In summary, the construction of a peak library derived from freshwater aquatic fungi ([Fig. 1] 
and Fig. 58S, Supporting Information), followed by the chemical study of the active extract 
obtained from fungal strain G858 (Delitschia sp.), led to the identification of eight new α-pyrone 
derivatives (1 – 7, and 11), as well as the new 3S*,4S*-7-ethyl-4,8-dihydroxy-3,6-dimethoxy-3,4-
dihydronaphthalen-1(2H)-one (15). The cytotoxicity of compounds 1, 2, 5 – 14, 16, and 17 was 
evaluated against an African American prostate cancer cell line (E006AA-hT), where 2, 13, 
and 14 showed activity. These results highlight the potential of fungi from underexplored 
environments as a source of new chemical entities, contributing to the expansion of the chemical 
space of natural products. 
 
Materials and Methods 
 
General experimental procedures 
 
Optical rotation and UV experiments were conducted using a Rudolph Research Autopol III 
polarimeter (Rudolph Research Analytical) and a Varian Cary 100 Bio UV-vis 
spectrophotometer (Varian Inc.). NMR data were obtained using either a JOEL ECA-500 NMR 
spectrometer operating at 500 MHz for 1H and 125 MHz for 13C (JOEL Ltd.) or an Agilent 
700 MHz NMR spectrometer equipped with a cryoprobe, operating at 700 MHz for 1H and 
175 MHz for 13C (Agilent Technologies). HRESIMS data were collected with a Thermo 
QExactive Plus mass spectrometer coupled with an electrospray ionization source (Thermo 
Fisher Scientific). The purity of the compounds (> 95%) was assessed by 1H-NMR (see 
Supporting Information) and using a Waters Acquity UPLC system paired with an Acquity BEH 
C18 column (1.7 µm; 50 mm × 2.1 mm) (Waters Corp.) and analyzed using the software 
XCalibur. Gemini-NX C18 analytical (5 µm; 250 × 4.6 mm), semipreparative (5 µm; 
250 × 10.0 mm), preparative (5 µm; 250 × 21.2 mm), Luna PFP semipreparative (5 µm; 
250 × 10.0 mm) and preparative (5 µm; 250 × 21.2 mm) columns (all from Phenomenex) along 
with Waters Atlantis T3 C18 semipreparative (5 µm; 250 × 10.0 mm) and preparative (5 µm; 
250 × 19.0 mm) columns were used for chromatographic separations. A Varian ProStar HPLC 
system equipped with ProStar 210 pumps, a ProStar 335 photodiode array detector, and Galaxie 
Chromatography Workstation software (version 1.9.3.2, Varian Inc.) was used for data collection 
and analysis. Flash chromatography was conducted on a Teledyne Isco CombiFlash Rf 200 
system using RediSep RF Gold HP silica columns (both from Teledyne Isco) that was coupled 
with UV and evaporative light-scattering detectors. All other reagents and solvents were 
obtained from Fisher Scientific. 
 
Fungal strain isolation and identification 
 
Specimen JF16003 was collected in Ariége, Rimont, France on submerged wood in LeBaup 
stream (September 2015) (Fig. 58S, Supporting Information) from which strain G858 was 
isolated. Based on micromorphological examination of the fruiting bodies obtained from the 
incubated wood, the fungus was identified as Delitschia sp. (Fig. 3S, Supporting Information). 
This fungus develops on long-time submerged wood as a dense greenish black sterile subiculum, 
and ascomata occur when the stream dries out or when the wood is washed out on the banks. In 
addition, the partial large subunit (LSU; 28S) rDNA region was sequenced to corroborate 
morphological observations, since the 28S ribosomal gene region for most previously 
described Delitschia sp. is available in GenBank for phylogenetic comparison. The partial LSU 
region was amplified using primer combination LROR and LR6 [34], [35] and Sanger sequenced 
using primers LROR, LR3, and LR6. For phylogenetic analysis, all available Delitschia sp. 
sequences from GenBank were aligned using a previously published LSU alignment of members 
of the Pleosporomycetidae, Dothideomycetes [36]; these included reports of Delitschia sp. from 
which fungal metabolites have been isolated [12], [13], [26]. Protocols for DNA extraction, PCR, 
Sanger sequencing, and phylogenetic analysis have been reviewed [37]. Results of the Maximum 
Likelihood (ML) analysis showed that strain G858 was nested within the family Delitschiaceae, 
Pleosporales, Dothideomycetes, Ascomycota with 100% ML bootstrap and was a sister 
to Delitschia sp. (FL1581) [12] with high bootstrap support (Fig. 3S, Supporting 
Information). Delitschia sp. have been reported from herbivore dung [12], [38], [39] and 
submerged wood in freshwater [26], [40]. This study provides molecular evidence 
that Delitschia is not restricted to a coprophilous lifestyle but can also be lignicolous (Fig. 4S, 
Supporting Information). The partial LSU sequences were deposited in GenBank (MF684774, 
MF684775). 
 
Fermentation, extraction, and isolation 
 
A fresh culture of fungal strain G858 was grown in a petri dish containing potato dextrose agar 
(PDA; Difco) with an autoclaved piece of balsa wood. Once sufficient mycelial growth was 
observed on the PDA plates, a small agar plug with fungal mycelium was cut out from the 
leading edge of the colony and transferred aseptically to eight 10-mL liquid YESD (2% soy 
peptone, 2% dextrose, and 1% yeast extract) seed cultures. The cultures were shaken at room 
temperature at 125 rpm for 14 days. Afterwards, the seed cultures were used to inoculate eight 
250-mL Erlenmeyer flasks with solid media (rice), prepared by autoclaving 10 g of rice with 
20 mL of distilled H2O; the flasks were incubated at room temperature for 28 days [8], [9]. 
 
A total of 60 mL of 1 : 1 MeOH-CHCl3 was added to each of the flasks followed by chopping into 
small pieces with a spatula. The samples were shaken overnight (~ 16 h) using a rotary shaker at 
~ 125 rpm at room temperature, filtered under vacuum, and the remaining solid portions were 
washed with small volumes of MeOH. The filtrates were combined, and 300 mL of both 
CHCl3 and H2O were added. This biphasic solution was stirred for 30 min and transferred to a 
separatory funnel in which a precipitate was collected prior to the organic layer being drawn off; 
both the organic phase and the precipitate were evaporated to dryness in vacuum. The organic 
extract was partitioned between 300 mL of 1 : 1 MeOH-CH3CN and 300 mL of hexanes. The 
MeOH-CH3CN layer was evaporated under reduced pressure to dryness [8], [21]. The defatted 
extract (~ 559 mg) was dissolved in CHCl3, then adsorbed onto Celite 545. The sample was 
fractionated by flash chromatography via a 24 g RediSep Rf Gold HP silica column using a 
gradient solvent system of hexane-CHCl3-MeOH at a 35 mL/min flow rate and 25.7 column 
volumes over 24.7 min to afford nine fractions (F1 – F9). Fraction 3 (63.6 mg) was subjected to 
preparative HPLC using a gradient system of 50 : 50 to 80 : 20 CH3CN-H2O (0.1% formic acid) 
over 30 min at a flow rate of 21.20 mL/min and a Gemini column to yield compound 14 
(4.6 mg, t R 18.0 min). Fraction 4 (73.8 mg) was subjected to preparative HPLC using a gradient 
system of 20 : 80 to 100 : 0 CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 
20.00 mL/min and a Gemini column to yield 10 subfractions (F4I-F4X). Subfractions F4I and 
F4IV afforded compounds 2 (1.3 mg) and 15 (2.0 mg), respectively. Fraction 5 (9.6 mg) was 
subjected to semipreparative HPLC using a gradient system of 40 : 60 to 70 : 30 CH3CN-H2O 
(0.1% formic acid) over 30 min at a flow rate of 4.60 mL/min and a Gemini column to yield 6 
subfractions, where subfraction 3 yielded compound 13 (2.5 mg, t R 13.7 min). Fraction 6 
(136.7 mg) was subjected to preparative HPLC using a gradient system of 10 : 90 to 50 : 50 
CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 21.20 mL/min and a Gemini 
column to yield 18 subfractions (F6I-F6XVIII). Subfractions F6I, F6IV, F6VI, F6VII, and F6XII 
afforded compounds 5 (10.3 mg, t R 10.1 min), 9 (1.0 mg, t R 14.9 min), 6 (8.7 mg, t R 16.0 min), 
1 (11.0 mg, t R 17.2 min), and 12 (0.9 mg, t R 22.1 min), respectively. Subfraction F6V (17.3 mg) 
was further purified with preparative HPLC using an isocratic system 25 : 75 CH3CN-H2O (0.1% 
formic acid) over 20 min at a flow rate of 21.20 mL/min and a Luna PFP column to yield 6 
subfractions, in which subfraction 1 afforded compound 10 (0.4 mg, t R 7.5 min). Subfraction 
F6X (6.8 mg) was further purified with semipreparative HPLC using a gradient system of 35 : 65 
to 45 : 55 CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 4.60 mL/min and a 
Gemini column to yield 4 subfractions (F6X1-F6X4), where F6X2, and F6X3 afforded compounds 4 
(1.6 mg, t R 9.8 min) and 3 (0.8 mg, t R 10.3 min), respectively. Fraction 7 (242.0 mg) was 
subjected to two different purification methods using preparative HPLC. Part of fraction 7 
(100.0 mg) was subjected to preparative HPLC using a gradient system of 20 : 80 to 100 : 0 
CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 17.00 mL/min and an Atlantis T3 
column to yield 9 subfractions (F7A – I-F7A-IX). Subfractions F7A-II and F7A-III afforded 
compounds 8 (3.7 mg, t R 8.0 min) and 7 (9.0 mg, t R 9.4 min), respectively. Part of fraction 7 
(100.0 mg) was subjected to preparative HPLC using a gradient system of 10 : 90 to 50 : 50 
CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 21.20 mL/min and a Luna PFP 
column to yield 18 subfractions, where subfraction 4 afforded compound 11 
(0.9 mg, t R 10.6 min). The precipitate obtained from the CHCl3-H2O partition (80.0 mg) was 
subjected to preparative HPLC using a gradient system of 60 : 40 to 90 : 10 CH3CN-H2O (0.1% 
formic acid) over 30 min at a flow rate of 21.20 mL/min and a Gemini column to yield 8 
subfractions. Subfraction 2 yielded compound 17 (1.3 mg), and subfractions 4 – 6 afforded 
compound 16 (47.1 mg). Compounds 3, 7, 8, and 15 were further purified by analytical and 
semipreparative HPLC to generate materials of a higher purity, while all other isolated 
compounds were at a suitable purity for biological evaluation. Various columns and gradients, 
including isocratic, were used with a mobile phase of CH3CN-H2O (0.1% formic acid) to yield 
compounds 3 (0.1 mg), 7 (2.3 mg), 8 (1.3 mg), and 15 (0.4 mg). 
 
Delitpyrone A (1): Colorless solid; [α]D 27 = − 15 (c 0.1, MeOH); UV (MeOH) λ max (log ε) 209 
(4.17), 284 (3.82) nm; 1H-NMR (CDCl3, 700 MHz) and 13C-NMR (CDCl3, 175 MHz), see 
[Tables 1] and [2]; HRESIMS m/z 213.1125 (calcd. for C11H17O4, 213.1121). 
 
1′,2′-Epoxi-delitpyrone A (2): Colorless solid; [α]D 26 = − 5 (c 0.04, MeOH); UV 
(MeOH) λ max (log ε) 208 (3.78), 284 (3.22) nm; 1H-NMR (CDCl3, 500 MHz) and 13C-NMR 
(CDCl3, 125 MHz), see [Tables 1] and [2]; HRESIMS m/z 211.0955 (calcd. for C11H15O4, 
211.0965). 
 
Delitpyrone B (3): Colorless solid; 1H-NMR (CDCl3, 700 MHz) and 13C-NMR (CDCl3, 
175 MHz), see [Tables 1] and [2]; HRESIMS m/z 229.1068 (calcd. for C11H17O5, 229.1070). 
 
Delitpyrone C (4): Colorless solid; 1H-NMR (acetone-d 6, 500 MHz) and 13C-NMR (acetone-d 6, 
125 MHz), see [Table 3]; HRESIMS m/z 211.0962 (calcd. for C11H15O4, 211.0965). 
 
2′-Oxodelitpyrone A (5): Colorless solid; [α]D 27 = − 38 (c 0.1, MeOH); UV (MeOH) λ max (log ε) 
208 (4.11), 276 (3.74) nm; 1H-NMR (CDCl3, 500 MHz) and 13C-NMR (CDCl3, 125 MHz), see 
[Tables 1] and [2]; HRESIMS m/z 227.0916 (calcd. for C11H15O5, 227.0914). 
 
Delitpyrone D (6): Colorless solid; UV (MeOH) λ max (log ε) 208 (4.30), 283 (3.94) nm; 1H-
NMR (CDCl3, 500 MHz) and 13C-NMR (CDCl3, 125 MHz), see [Tables 1] and [2]; 
HRESIMS m/z 211.0967 (calcd. for C11H15O4, 211.0965). 
 
Delitpyrone E (7): Colorless solid; [α]D 27 = + 17 (c 0.13, MeOH); UV (MeOH) λ max (log ε) 210 
(3.92), 285 (3.65) nm; 1H-NMR and 13C-NMR (MeOH-d 4, 500 MHz), see [Tables 1] and [2]; 
HRESIMS m/z 213.1122 (calcd. for C11H17O4, 213.1121). 
 
5-(3-S-Hydroxybutyl)-4-methoxy-6-methyl-2H-pyran-2-one (8): Colorless solid; [α]D 27 = + 7 
(c 0.09, MeOH); UV (MeOH) λ max (log ε) 210 (3.73), 284 (3.41) nm; 1H-NMR and 13C-NMR 
(MeOH-d 4, 500 MHz), see Supporting Information; HRESIMS m/z 213.1121 (calcd. for 
C11H17O4, 213.1121). 
 
4-Methoxy-6-methyl-5-(3-oxobutyl)-2H-pyran-2-one (9): Colorless solid; UV 
(MeOH) λ max (log ε) 207 (3.67), 281 (3.12) nm; 1H-NMR (MeOH-d 4, 500 MHz) and 13C-NMR 
(MeOH-d 4, 125 MHz), see Supporting Information; HRESIMS m/z 211.0968 (calcd. for 
C11H15O4, 211.0965). 
 
Pyrenocine I (10): Colorless solid; UV (MeOH) λ max (log ε) 232 (3.75), 284 (3.41) nm; 1H-NMR 
and 13C-NMR (CDCl3, 500 MHz), see Supporting Information; HRESIMS m/z 211.0965 (calcd. 
for C11H15O4, 211.0965). 
 
3′-Hydroxydelitpyrone D (11): Colorless solid; UV (MeOH) λ max (log ε) 211 (3.53), 2863 (3.43) 
nm; 1H-NMR and 13C-NMR (CDCl3, 500 MHz), see [Tables 1] and [2]; HRESIMS m/z 227.0914 
(calcd. for C11H15O5, 227.0914). 
 
3S*,4S*-7-Ethyl-4,8-dihydroxy-3,6-dimethoxy-3,4-dihydronaphthalen-1(2H)-one (15): Yellow 
solid; 1H-NMR and 13C-NMR (CDCl3, 700 MHz), see [Table 4]; HRESIMS m/z 267.1224 
(calcd. for C14H19O5, 267.1227). 
 
Preparation of the (R)- and (S)-MTPA ester derivatives of compounds 1, 7, and 8 
 
Independently, a total of 0.10 mg of compounds 1, 7, and 8 were mixed with 400 µL of pyridine-
d 5 and transferred into NMR tubes. The reactions were initiated with the addition of 4 µL of S-
(+)-α-methoxy-α-(trifluoromethyl)phenylacetyl (MTPA) chloride into each NMR tube. The 
tubes were carefully shaken and then immediately monitored by 1H-NMR at 5, 10, and 15 min 
increments, with the reactions being completed by 10 min, yielding the mono (R)-MTPA ester 
derivatives of 1, 7, and 8 (1b, 7b, and 8b, respectively). The (S)-MTPA ester derivatives of 
compounds 1, 7, and 8 (1a, 7a, and 8a, respectively) were prepared in an analogous similar 
fashion [9]. 
 
Cell viability assay 
 
African American cancer cells (E006AA-hT) were obtained from Dr. Koochekpour (Roswell 
Park Memorial Institute). Cells were treated with 1, 2, 5 – 14, 16, and 17 (2.5 – 40 µM, in DMSO) 
and cultured under hypoxia (1% O2) for 48 h. An equal amount of DMSO was present in each 
treatment, including the control; the concentration of DMSO did not exceed 0.1% (v/v) in any 
treatment. Cell viability was measured using the MTT reagent, as detailed below. As a positive 
control, we used the HIF2α inhibitor TC-S7009, which in our other completed studies inhibited 
E006AA-hT cell viability with an IC50 value of ~ 20 µM; HIF2α inhibitors are important 
anticancer molecules [41]. TC-S7009 (≥ 99% purity) was procured from Tocris Bioscience 
(Avonmouth, Bristol). 
 
For the MTT assay, 2000 E006AA-hT cells in 200 µL of media were dispensed in a 96-well 
plate on day 1, followed by exposure to 1, 2, 5 – 14, 16, and 17 at concentrations of 2.5 – 40 µM 
on day 2, and then cultured under hypoxic conditions (1% oxygen concentration). After 48 h of 
hypoxia treatment, 20 µL of MTT (5 mg/mL PBS) were added to each well. The plates were 
further incubated for 2 h. Following completion of the incubation time, the medium was 
decanted, the formazan formed was dissolved in 200 µL of DMSO, and, after 10 min, absorbance 
was measured at 550 and 660 nm on a microplate reader. 
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